Compare VTR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTR | STE |
|---|---|---|
| Founded | 1983 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 25.9B |
| IPO Year | 1998 | 1992 |
| Metric | VTR | STE |
|---|---|---|
| Price | $77.79 | $251.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $78.43 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 3.2M | 619.9K |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.47% | 1.00% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 0.53 | ★ 6.97 |
| Revenue | $5,544,046,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $17.34 | $9.61 |
| Revenue Next Year | $10.07 | $6.23 |
| P/E Ratio | $147.59 | ★ $36.07 |
| Revenue Growth | ★ 16.38 | 7.08 |
| 52 Week Low | $56.68 | $200.98 |
| 52 Week High | $81.89 | $268.60 |
| Indicator | VTR | STE |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 42.03 |
| Support Level | $76.14 | $256.63 |
| Resistance Level | $81.89 | $261.45 |
| Average True Range (ATR) | 1.38 | 4.93 |
| MACD | -0.62 | -1.82 |
| Stochastic Oscillator | 30.35 | 10.41 |
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.